MyFinsight
Home
Blog
About
Marketable securities
$105,892K
(966.17%↑ Y/Y)
Cash and cash
equivalents
$11,327K
(-60.14%↓ Y/Y)
Prepaid expenses and
other current assets
$6,398K
(70.98%↑ Y/Y)
Total current assets
$123,617K
(193.70%↑ Y/Y)
Marketable securities -
noncurrent
$52,550K
Net carrying value
for the period ended...
$42,694K
Right-of-use asset, net
$10,980K
(-10.11%↓ Y/Y)
Restricted cash
$1,931K
(0.00%↑ Y/Y)
Property and equipment,
net
$201K
(-29.47%↓ Y/Y)
Total assets
$231,973K
(199.60%↑ Y/Y)
Total liabilities and
stockholders equity
$231,973K
(199.60%↑ Y/Y)
Total stockholders
equity
$209,890K
(276.22%↑ Y/Y)
Total liabilities
$22,083K
(2.05%↑ Y/Y)
Accumulated deficit
-$353,710K
(-10.81%↓ Y/Y)
Accumulated other
comprehensive loss
-$750K
(-986.96%↓ Y/Y)
Additional
paid-in-capital
$564,165K
(50.44%↑ Y/Y)
Lease liability
$11,231K
(-11.67%↓ Y/Y)
Total current
liabilities
$9,980K
(11.83%↑ Y/Y)
Royalty monetization
liability
$872K
Common stock, 0.001 par
value 315,000,000...
$185K
(160.56%↑ Y/Y)
Accrued expenses
$4,424K
(54.04%↑ Y/Y)
Accounts payable
$4,072K
(3.09%↑ Y/Y)
Current portion, lease
liability
$1,484K
(7.23%↑ Y/Y)
Back
Back
Balance Sheet
Ovid Therapeutics Inc. (OVID)
Ovid Therapeutics Inc. (OVID)
source: myfinsight.com